Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Biological Psychiatry|April 1, 1987
Increased CSF amino acids and ventricular enlargement in schizophrenia: a preliminary studyM A Reveley, J De Belleroche, A Recordati, et al.
Annals of Allergy|July 1, 1994
Evaluation of nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitisJ Melamed, R H Schwartz, S R Hirsch, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1992
Inositol phospholipid turnover in platelets of schizophrenic patientsI Das, M A Essali, J de Belleroche, et al.
JAMA|November 21, 1980
Intact antibody response to pneumococcal capsular polysaccharides in uremia and diabetesE A Friedman, M M Beyer, S R Hirsch, et al.
Schizophrenia Research|June 1, 1994
Elevated platelet phosphatidylinositol bisphosphate in mediated schizophrenicsI Das, M A Essali, J de Belleroche, et al.
Neuroscience Letters|September 13, 1996
Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide productionI Das, N S Khan, B K Puri, et al.
Biological Psychiatry|September 15, 1990
The platelet polyphosphoinositide system in schizophrenia: the effects of neuroleptic treatmentM A Essali, I Das, J de Belleroche, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1997
A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunctionS R Hirsch, I Das, L J Garey, et al.
Biological Psychiatry|March 1, 1985
Pathway and hemispheric differences in the event-related potential (ERP) to monaural stimulation: a comparison of schizophrenic patients with normal controlsJ F Connolly, R Manchanda, J H Gruzelier, et al.
Schizophrenia Research|September 10, 1999
Symptom dimensions in old-age schizophrenics. Relationship to neuropsychological and motor abnormalitiesH Sauer, C Hornstein, P Richter, et al.
Pageof 9